| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/02/2004 | CA2516452A1 Estradiol metabolites for the treatment of pulmonary hypertension |
| 09/02/2004 | CA2516335A1 A method of diagnosis and treatment |
| 09/02/2004 | CA2516282A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | CA2515612A1 Activated polyethylene glycol esters |
| 09/02/2004 | CA2514277A1 Methods and compositions for administering therapeutic and diagnostic agents |
| 09/01/2004 | EP1452546A2 Poly-beta-1,4-N-Acetyglucosamine |
| 09/01/2004 | EP1452543A2 RGD (ARG-GLY-ASP) coupled to (neuro)peptides |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452182A1 Angiogenesis drugs |
| 09/01/2004 | EP1452177A1 Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent |
| 09/01/2004 | EP1452174A1 METHOD OF STABILIZING REDUCED COENZYME Q sb 10 /sb |
| 09/01/2004 | EP1452173A1 UV-stable transdermal patch |
| 09/01/2004 | EP1452171A2 Pharmaceutical liquid suspensions |
| 09/01/2004 | EP1451571A2 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same |
| 09/01/2004 | EP1451242A1 Water-in-silicone emulsions |
| 09/01/2004 | EP1451219A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 09/01/2004 | EP1451184A1 Dimeric compounds and their use as anti-viral agents |
| 09/01/2004 | EP1451183A1 Dimeric compounds and their use as anti-viral agents |
| 09/01/2004 | EP1451181A1 Dimeric compounds and their use as anti-viral agents |
| 09/01/2004 | EP1451146A1 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof |
| 09/01/2004 | EP1451104A1 Calcium metasilicates and methods for making the same |
| 09/01/2004 | EP1450864A2 Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy |
| 09/01/2004 | EP1450861A2 Targeting nucleic acids to a cellular nucleus |
| 09/01/2004 | EP1450858A2 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist |
| 09/01/2004 | EP1450855A2 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 09/01/2004 | EP1450847A2 Apo2 ligand/trail formulations |
| 09/01/2004 | EP1450846A2 Self-assembling polymers, and materials fabricated therefrom |
| 09/01/2004 | EP1450844A2 Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 09/01/2004 | EP1450842A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 09/01/2004 | EP1450829A1 Storage-stable fibrinogen solutions |
| 09/01/2004 | EP1450822A2 Polymeric thiol-linked prodrugs |
| 09/01/2004 | EP1450804A1 Pharmaceutical formulations comprising an immune response modifier |
| 09/01/2004 | EP1450798A1 Use of an ascomycin for the treatment of blepharitis |
| 09/01/2004 | EP1450789A1 STABLE, ACID, AQUEOUS SOLUTION CONTAINING a-LIPONIC ACID (DER IVATIVES), METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME |
| 09/01/2004 | EP1450786A1 Isoflavone concentrate and method for production thereof |
| 09/01/2004 | EP1450785A1 Method of treating dermatoses using avermectin compound |
| 09/01/2004 | EP1450783A1 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma |
| 09/01/2004 | EP1450772A1 Micronized film-forming powder comprising an active substance |
| 09/01/2004 | EP1450770A2 Pharmaceutical composition comprising a 5ht1 receptor agonist |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1450768A1 Oral controlled release forms useful for reducing or preventing nicotine cravings |
| 09/01/2004 | EP1450767A1 Micropherules containing a pleuromutilin derivative |
| 09/01/2004 | EP1450766A1 Prolonged release biodegradable microspheres and method for preparing same |
| 09/01/2004 | EP1450765A2 Sustained-release compositions |
| 09/01/2004 | EP1450762A1 Novel formulation |
| 09/01/2004 | EP1450756A1 Surfactant-containing cosmetic cleaning emulsions |
| 09/01/2004 | EP1450753A1 Antimicrobial composition comprising soy oil, rice bran oil and jojoba oil |
| 09/01/2004 | EP1450751A2 Nanoparticle delivery vehicle |
| 09/01/2004 | EP1450749A1 Taste masked aqueous liquid pharmaceutical composition |
| 09/01/2004 | EP1450739A1 Hydrating nasal gel and applicator |
| 09/01/2004 | EP1450629A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 09/01/2004 | EP1368041B1 Amphotericin b aqueous composition |
| 09/01/2004 | EP1325044B1 Aqueous polymer dispersion |
| 09/01/2004 | EP1280538B1 Compositions containing molecular iodine |
| 09/01/2004 | EP1223914B1 Orally distintegrating composition comprising mirtazapine |
| 09/01/2004 | EP1220659B1 Pharmaceutical products and methods of fabrication therefor |
| 09/01/2004 | EP1194131B1 Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| 09/01/2004 | EP1173245B1 Compositions for aerosolization and inhalation |
| 09/01/2004 | EP1133271B1 Method of producing solid dosage forms |
| 09/01/2004 | EP1131037B1 Process for the manufacture of liquid filled capsules |
| 09/01/2004 | EP1123008A4 Preparation and use of solidified oils |
| 09/01/2004 | EP1089745B1 Oregano for the treatment of internal parasites and protozoa |
| 09/01/2004 | EP1083880B1 Stable gel mixture in the form of a mixture of oleogel and aqueous gel |
| 09/01/2004 | EP1024824B1 Solid dispersing vaccine composition for oral delivery |
| 09/01/2004 | EP0984771A4 Stabilized gas-supersaturated emulsions and suspensions |
| 09/01/2004 | EP0764172B1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 09/01/2004 | CN1526016A Method for stabilization of nucleic acids |
| 09/01/2004 | CN1525869A Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 09/01/2004 | CN1525866A Treatment using neublastin polypeptides |
| 09/01/2004 | CN1525857A Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives |
| 09/01/2004 | CN1525856A Stable high-concentration injection containing pyrazolone derivative |
| 09/01/2004 | CN1525855A Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
| 09/01/2004 | CN1525852A Granules and granules coated with a masked taste |
| 09/01/2004 | CN1525851A Abuse-resistant controlled-release opioid dosage form |
| 09/01/2004 | CN1525849A Olopatadine formulations for topical administration |
| 09/01/2004 | CN1524582A Special auxiliary materials for floating slow-release tablet and preparation method thereof |
| 09/01/2004 | CN1524581A Polymer micelle medicine-carrying system |
| 09/01/2004 | CN1524580A Carmustine slow-release tablet and its preparation method |
| 09/01/2004 | CN1524578A Dry heat processing stabilizer for prothrombin complex or factor v a IX preparation |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164756C Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 09/01/2004 | CN1164675C Polymeric composition for solubilizing poorly water soluble drugs and process for preparation thereof |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 09/01/2004 | CN1164333C Recombinant basic fibroblast growth factor protection agent |
| 09/01/2004 | CN1164271C Stable xylometazoline and oxymetazoline solution |
| 09/01/2004 | CN1164267C Medical use of Chlorogenic acid and formulation thereof |
| 09/01/2004 | CN1164263C Ambroxol-containing suctorial type tablet |
| 09/01/2004 | CN1164262C Granules containing a plant substance and method for producing the same |
| 09/01/2004 | CN1164261C Liposome preparation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
| 08/31/2004 | USRE38576 Stabilized aspirin compositions and method of preparation for oral and topical use |
| 08/31/2004 | US6784266 Block polymers having both thermo- and ph- responsive properties necessary for drug delivery systems; copolymers based on a sulfonamide derivative of styrene (ph) and n-isopropylacrylamide (heat); sulfa drugs |
| 08/31/2004 | US6784186 Opiods which have less activity within the central nervous system, thus having fewer undesirable side-effects |
| 08/31/2004 | US6784153 Identify molecules that can bind to organ or tissue specific markers and, therefore, can home to the organ or tissue; membrane dipeptidase (mdp)-binding homing molecule, which is a molecule that selectively homes to lung endothelium |
| 08/31/2004 | US6783965 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 08/31/2004 | US6783931 Amine-derivatized nucleosides and oligonucleosides |
| 08/31/2004 | US6783779 Food products coated with 1, 6-GPS and 1, 1-GPM |
| 08/31/2004 | US6783770 Hard capsules comprising polymers of vinyl esters and polyethers, their use and production |
| 08/31/2004 | US6783769 Layer of a tolterodine containing a matrix composition disposed on film, matrix is solid solution of copolymer of ethyl acrylate and methyl methacrylate and about 5% trimethylammonium ethyl methacrylate chloride and plasticizer |
| 08/31/2004 | US6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |